Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

494 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Convalescent plasma therapy in patients with COVID-19.
Yiğenoğlu TN, Hacıbekiroğlu T, Berber İ, Dal MS, Baştürk A, Namdaroğlu S, Korkmaz S, Ulas T, Dal T, Erkurt MA, Turgut B, Altuntaş F. Yiğenoğlu TN, et al. Among authors: korkmaz s. J Clin Apher. 2020 Aug;35(4):367-373. doi: 10.1002/jca.21806. Epub 2020 Jul 9. J Clin Apher. 2020. PMID: 32643200 Free PMC article. Review.
Convalescent plasma therapy in patients with COVID-19.
Altuntas F, Ata N, Yigenoglu TN, Bascı S, Dal MS, Korkmaz S, Namdaroglu S, Basturk A, Hacıbekiroglu T, Dogu MH, Berber İ, Dal K, Kınık K, Haznedaroglu İ, Yılmaz FM, Kılıç İ, Demircioğlu S, Yosunkaya A, Erkurt MA, Turgut B, Caglayan M, Celik O. Altuntas F, et al. Among authors: korkmaz s. Transfus Apher Sci. 2021 Feb;60(1):102955. doi: 10.1016/j.transci.2020.102955. Epub 2020 Sep 19. Transfus Apher Sci. 2021. PMID: 33011076 Free PMC article.
Convalescent plasma therapy in patients with COVID-19.
Altuntas F, Yigenoglu TN, Bascı S, Dal MS, Korkmaz S, Turgut B, Erkurt MA. Altuntas F, et al. Among authors: korkmaz s. Transfus Apher Sci. 2021 Feb;60(1):103017. doi: 10.1016/j.transci.2020.103017. Epub 2020 Nov 19. Transfus Apher Sci. 2021. PMID: 33277207 Free PMC article. No abstract available.
The outcome of COVID-19 in patients with hematological malignancy.
Yigenoglu TN, Ata N, Altuntas F, Bascı S, Dal MS, Korkmaz S, Namdaroglu S, Basturk A, Hacıbekiroglu T, Dogu MH, Berber İ, Dal K, Erkurt MA, Turgut B, Ulgu MM, Celik O, Imrat E, Birinci S. Yigenoglu TN, et al. Among authors: korkmaz s. J Med Virol. 2021 Feb;93(2):1099-1104. doi: 10.1002/jmv.26404. Epub 2020 Aug 26. J Med Virol. 2021. PMID: 32776581 Free PMC article.
Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors.
Başcı S, Ata N, Altuntaş F, Yiğenoğlu TN, Dal MS, Korkmaz S, Namdaroğlu S, Baştürk A, Hacıbekiroğlu T, Doğu MH, Berber İ, Dal K, Erkurt MA, Turgut B, Çağlayan M, Ayvalı MO, Çelik O, Ülgü MM, Birinci Ş; Turkish Ministry of Health, Hematology Scientific Working Group. Başcı S, et al. Among authors: korkmaz s. J Oncol Pharm Pract. 2020 Oct;26(7):1676-1682. doi: 10.1177/1078155220953198. Epub 2020 Aug 27. J Oncol Pharm Pract. 2020. PMID: 32854573 Free PMC article.
The outcome ofancy. COVID-19 in patients with hematological malign.
Yigenoglu TN, Bascı S, Dal MS, Korkmaz S, Turgut B, Altuntas F. Yigenoglu TN, et al. Among authors: korkmaz s. J Med Virol. 2021 Mar;93(3):1255. doi: 10.1002/jmv.26607. Epub 2020 Nov 1. J Med Virol. 2021. PMID: 33064307 Free PMC article. No abstract available.
COVID-19 clinical course and blood groups: Turkish population-based study.
Dal MS, Ata N, Altuntaş F, Başcı S, Yiğenoğlu TN, Korkmaz S, Namdaroğlu S, Baştürk A, Hacıbekiroğlu T, Doğu MH, Berber İ, Dal K, Erkurt MA, Turgut B, Çağlayan M, Imrat E, Çelik O, Ülgü MM, Birinci Ş. Dal MS, et al. Among authors: korkmaz s. Turk J Med Sci. 2021 Aug 30;51(4):1659-1664. doi: 10.3906/sag-2101-321. Turk J Med Sci. 2021. PMID: 33957720 Free article.
494 results